Merdeka Gold Resources Tbk. vs Indofarma Tbk. — how do they compare? Merdeka Gold Resources Tbk. trades at Rp8,750 (market cap 126.69T, 21.27M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Merdeka Gold Resources Tbk. is far larger — about 324.4× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| EMAS | INAF | |
|---|---|---|
Market Cap | 126.69T | 390.51B |
Volume | 21.27M | — |
Lot | 212.69K | — |
Turnover | 185.05B | — |
Average Price | 8,700.43 | — |
Value | 185.05B | — |
Indicative Equilibrium Price | 8,750 | — |
Indicative Equilibrium Volume | 10.1K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Merdeka Gold Resources Tbk (formerly PT Pani Bersama Jaya) (the Company), was established in Republic of Indonesia based on Deed of Establishment No. 87 dated 20 November 2015 made before Humberg Lie, S.H., S.E., M.Kn., Notary in North Jakarta. The ultimate parent entity of the Company is PT Merdeka Copper Gold Tbk (MCG). Meanwhile, MCG is jointly controlled by PT Provident Capital Indonesia and PT Saratoga Investama Sedaya Tbk, which are respectively controlled by Winato Kartono and Edwin Soeryadjaya.
Read more on EMAS →PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →